What Coroneo does

Coroneo is a privately held medical device manufacturing company headquartered in Montréal, Canada, that develops novel cardiac implants for aortic valve repair. Founded in 1997 and operating with a workforce of 11–50 employees, the company is led by its co-founders Anthony Paolitto (CEO, President & Co-Founder) and Valerio Valentini (Vice President & Co-Founder). The firm's focus on cardiac implants positions it within a specialized segment of the cardiovascular device market, where regulatory clearances, surgeon adoption, and clinical evidence are the primary determinants of commercial traction.

The company's product offering centers on hardware-based implantable devices for aortic valve repair, but specific product names, technical specifications, regulatory approvals, and clinical milestones are not documented in the available sources. No patents, trademarks, certifications, or proprietary technology descriptions are disclosed. The public-facing website currently displays only a verification page with no operational content, further limiting visibility into the company's active product portfolio, pipeline, or commercialization status.

Coroneo's business model cannot be characterized in detail from the provided inputs: no pricing models, distribution channels, customer segments, sales channels, or revenue mechanics are documented. As a small, privately held medical device manufacturer operating in a regulated cardiac implant category, the company would conventionally generate revenue through direct hospital sales, distributor partnerships, or licensing arrangements, but no such structure is confirmed in the data. The company is referenced as a participant in a broader medical implants market projected to reach $2.01 billion by 2030, providing only an external market context rather than company-specific commercial validation. Overall, the evidence base is thin, and significant due diligence would be required to characterize the company's current operating, commercial, and financial position.

Name

Coroneo

Website

https://coroneo.com

Company type

Private

Founded year

1997

Headcount range

1–10 employees

Short description

Coroneo is a privately held Montréal-based medical device manufacturer that develops novel cardiac implants for aortic valve repair, serving cardiac surgery markets with a small specialized team led by its co-founders since 1997.

Ownership category

akta.pro rank

Product category

Cardiac Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Structural Heart Valves (TAVR/SAVR) & Valve Repair (HLAHAFAB)

akta.pro secondary industry

Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH)

Keywords

• Cardiac implants
• Aortic valve repair
• Medical devices
• Cardiac surgery devices
• Valve annuloplasty

Headquarters

HQ city

Montréal

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Core offering

Coroneo is a medical device manufacturing company that develops and produces novel cardiac implants designed for aortic valve repair. The company focuses on engineering implantable devices used by cardiac surgeons to repair, rather than replace, the aortic valve, supporting reconstructive cardiac surgery procedures.

Differentiator

Problem solved

Functional benefit

Products and services

• Cardiac implants for aortic valve repair

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves3 records

Expansion highlights3 records

Direct peers

• Medtronic: Sells the CoreValve Evolut TAVR system and a broader structural heart portfolio. Competes head-to-head in aortic valve procedures and represents a leading incumbent Coroneo must differentiate against.
• Edwards Lifesciences: Global leader in structural heart devices, including the market-leading Sapien TAVR platform. Directly comparable to Coroneo as the dominant aortic valve player against which any aortic valve repair implant must compete.
• CryoLife (Artivion): Focused on cardiac and vascular surgery, including heart valve products and tissue implants. Comparable niche cardiovascular implant developer operating a similar commercial model.
• JenaValve Technology: Specialist developer of transcatheter aortic valve replacement devices for aortic regurgitation. Closely comparable to Coroneo as a smaller, focused structural heart implant developer targeting the same procedural niche.
• Abbott: Offers structural heart solutions including Tendyne (TMVR) and Portico (TAVR), directly active in the aortic and mitral valve replacement/repair space alongside Coroneo's target indication.

Emerging players

• Colibri Heart Valve: Pre-commercial developer of transcatheter aortic valve replacement technology. Comparable as a smaller valve-repair-focused device company navigating similar regulatory and clinical pathways.
• Foldax: Developer of polymer-based heart valve implants. Comparable small-scale structural heart implant developer focused on differentiated valve technology, mirroring Coroneo's implant-specialist model.
• Micro Interventional Devices: Small developer of percutaneous structural heart devices targeting valve repair/replacement. Comparable emerging structural heart implant company with similar scale and commercialization profile.

Broad incumbents

• Boston Scientific: Diversified cardiovascular device manufacturer with structural heart exposure (e.g., ACURATE neo TAVR platform in select markets). An established broader incumbent that competes for hospital structural heart budgets.
• LivaNova: Cardiac surgery and structural heart player with heart valve franchises. Overlaps with Coroneo in valve-related implant markets and provides hospital procurement competition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Coroneo